Kiniksa Pharmaceuticals International Plc (KNSA)
77.09
-0.82
(-1.05%)
USD |
NASDAQ |
Sep 08, 16:00
80.00
+2.91
(+3.77%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Profit Margin (Quarterly) : 10.44% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.44% |
| March 31, 2026 | 10.54% |
| December 31, 2025 | 7.02% |
| September 30, 2025 | 10.19% |
| June 30, 2025 | 11.37% |
| March 31, 2025 | 6.20% |
| December 31, 2024 | -7.25% |
| September 30, 2024 | -11.31% |
| June 30, 2024 | -3.60% |
| March 31, 2024 | -22.17% |
| December 31, 2023 | 30.26% |
| Date | Value |
|---|---|
| September 30, 2023 | -20.66% |
| June 30, 2023 | 20.95% |
| March 31, 2023 | -25.38% |
| December 31, 2022 | 7.21% |
| September 30, 2022 | |
| June 30, 2022 | -74.08% |
| March 31, 2022 | -78.32% |
| December 31, 2021 | -193.8% |
| September 30, 2021 | -252.5% |
| June 30, 2021 | -539.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.11% |
| Return on Assets | 10.45% |
| Return on Invested Capital | 13.88% |
| Gross Profit Margin (Quarterly) | 54.10% |
| Operating Margin (Quarterly) | 11.16% |
| Return on Net Operating Assets | 71.02% |